Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101)

• Pieter J. Gaillard ,

  * E-mail: PieterGaillard@toBBB.com

  Affiliation to-BBB technologies BV, Leiden, The Netherlands

  ⨯
• Chantal C. M. Appeldoorn,

  Affiliation to-BBB technologies BV, Leiden, The Netherlands

  ⨯
• Rick Dorland,

  Affiliation to-BBB technologies BV, Leiden, The Netherlands

  ⨯
• Joan van Kregten,

  Affiliation to-BBB technologies BV, Leiden, The Netherlands

  ⨯
• Francesca Manca,

  Affiliation to-BBB technologies BV, Leiden, The Netherlands

  ⨯
• Danielle J. Vugts,

  Affiliation Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands

  ⨯
• Bert Windhorst,

  Affiliation Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands

  ⨯
• Guus A. M. S. van Dongen,

  Affiliation Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands

  ⨯
• Helga E. de Vries,

  Affiliation Blood-Brain Barrier Research Group, Molecular Cell Biology and Immunology, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands

  ⨯
• David Maussang,

  Affiliation to-BBB technologies BV, Leiden, The Netherlands

  ⨯
• Olaf van Tellingen

  Affiliation The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AvL), Amsterdam, The Netherlands

  ⨯